We're building an open standard and unified platform
About Atgenomix
We want to help you operationalize biomedical data, analytics, and machine learning to deliver on the promise of precision medicine.
​
As a data and machine learning (ML) company, we envision the cloud technology that will transform healthcare in routine clinical genomics and artificial intelligence. We aim to provide you with the computational technologies that you need to scale data and machine learning in the labs of the future.
​
We empower you to build your own fully-managed precision medicine production at scale and speed with an integrated solution stack of cloud services, software technologies, and industry standards.
More specifically, we help:
-
Next Generation Sequencing (NGS) testing providers scale clinical diagnostics portfolio globally
-
Clinical researchers accelerate large-scale multi-comics data processing
-
Bioinformatics developers release new analysis software products at record-breaking speed
​
Atgenomix is a Microsoft Azure cloud partner in gold data and cloud platform competencies, a Google Health trusted partner in genomics research, and a Health Level Seven (HL7) International Gold member.
Our mission
Manage genomic data and build a reliable BioMed IT platform
We are building a platform where you can quickly and accurately unlock complex genomic insights.
​
Genomic medicine is never easy and requires multi-disciplinary fields. We believe that life science and data science are better together. We manage the heavy lifting that data engineering requires so that you can focus on insight interpretation.
Our team
We are a multidisciplinary bio-IT team
We want to empower you to achieve more with our smart high-performance parallel computing to deliver on the promise of precision medicine.
Our customers
We help NGS testing service providers & medical centers
Our current client list includes next generation sequencing (NGS) testing service providers and medical centers that focus on the following services and areas of research:
-
Commercial cancer panels
-
Non-invasive prenatal tests (NIPT)
-
Preimplantation genetic screening
-
Clinical whole exome
-
Psychiatric discorders
-
Small cell lung cancer
-
Hepatocellular carcinoma
-
Cancer genomics research and database
